TNFRSF13B and Miyoshi myopathy: Atacicept is designed to bind and inactivate both BAFF and APRIL in their soluble form and thereby to inhibit their signaling.69 Because TACI expression on MMCs correlates directly with BM dependency, there is a strong rationale for the use of atacicept in MM.